Prednisolone enhances beta-cell function independently of ambient glycemic levels in type II diabetes.
This study examined the changes in beta-cell response and insulin sensitivity induced by a single overnight dose of 15 mg prednisolone in eight type II diabetic subjects, seven nondiabetic normal controls, and eight subjects with a first-degree type II diabetic relative who were therefore at risk of...
Κύριοι συγγραφείς: | Hosker, J, Burnett, M, Matthews, DR, Turner, R |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
1993
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Suppression of insulin secretion by falling plasma glucose levels is impaired in type 2 diabetes.
ανά: Hosker, J, κ.ά.
Έκδοση: (1988) -
Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy.
ανά: Hosker, J, κ.ά.
Έκδοση: (1989) -
ASSESSMENT OF B-CELL FUNCTION AND INSULIN RESISTANCE IN TYPE-II DIABETES BY CONTINUOUS INFUSION OF GLUCOSE WITH MODEL ASSESSMENT (CIGMA)
ανά: Turner, R, κ.ά.
Έκδοση: (1985) -
LOSS OF NORMAL SIGMOID, BETA-CELL DOSE-RESPONSE CURVE TO GLUCOSE IN NON-INSULIN-DEPENDENT DIABETES
ανά: Hosker, J, κ.ά.
Έκδοση: (1984) -
The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates.
ανά: Rudenski, A, κ.ά.
Έκδοση: (1988)